Inhaled budesonide for COVID-19 in the community: An update
Tutorial presented by Professor Chris Butler, a professor of primary care at the University of Oxford, professor of primary care medicine at Cardiff University, and a practising GP in Cwm Taf University Health Board. Chris is one of the lead investigators of the University of Oxford PRINCIPLE trial.
Following the publication of the findings from the PRINCIPLE trial in the Lancet, exploring the effectiveness of inhaled budesonide for COVID-19 in high-risk individuals not admitted to hospital, Professor Chris Butler returned to the studio to provide an update on the findings, including a summary of the results, who should be considered for this therapy, and answering some frequently asked questions.
If you missed the first episode, where Chris outlines the preliminary findings of the trial, you can also find that linked below.
Tutorial presented by Professor Chris Butler, a professor of primary care at the University of Oxford, professor of primary care medicine at Cardiff University, and a practising GP in Cwm Taf University Health Board. Chris is one of the lead investigators of the University of Oxford PRINCIPLE trial.
Following the publication of the findings from the PRINCIPLE trial in the Lancet, exploring the effectiveness of inhaled budesonide for COVID-19 in high-risk individuals not admitted to hospital, Professor Chris Butler returned to the studio to provide an update on the findings, including a summary of the results, who should be considered for this therapy, and answering some frequently asked questions.
If you missed the first episode, where Chris outlines the preliminary findings of the trial, you can also find that linked below.
![]() |
---|
PRINCIPLE: a randomised, controlled, open-label, adaptive platform trial